Titlebook: Antibody Therapy; Substitution – Immun Paul Imbach Book 2018 Springer International Publishing AG, part of Springer Nature 2018 Immunoglobu

Animosity

書目名稱Antibody Therapy影響因子(影響力)




書目名稱Antibody Therapy影響因子(影響力)學(xué)科排名




書目名稱Antibody Therapy網(wǎng)絡(luò)公開度




書目名稱Antibody Therapy網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Antibody Therapy被引頻次




書目名稱Antibody Therapy被引頻次學(xué)科排名




書目名稱Antibody Therapy年度引用




書目名稱Antibody Therapy年度引用學(xué)科排名




書目名稱Antibody Therapy讀者反饋




書目名稱Antibody Therapy讀者反饋學(xué)科排名

條街道往前推

From Immune Substitution to Immuno-modulationestones in the history of human immunoglobulins since the initial observation by Ogden C. Bruton who described replacement therapy in a single boy with agammaglobulinemia. Since then, the preparations used for treatment have been markedly improved with respect to tolerability, clinical efficacy, and

搬運(yùn)工

知識(shí)

吼叫

Immunomodulatory Drugs and Monoclonal Antibodies development of most such disorders, but an external trigger may be required for the eventual development of the autoimmune disease. The development of pharmacologic agents to treat such disorders by inducing self-tolerance has progressed over the last 60?years. Historically termed immunosuppressive

Aerate

混合,攙雜

Expiration

惡臭

Essentials of the?Production of Safe and Efficacious State-of-the-Art Polyclonal IgG Concentratesal use were threats for recipients (see Chap. . for additional information). “Standard IgG” preparations were the first available for clinical use. They were produced by the cold-ethanol fractionation methods and did not make an exception. Noninfectious severe AEs occurred while infectious AEs were

不溶解